New knowledge of epigenetics and biology promises new treatments that are much more precise and effective. A strong American pharmaceutical industry is essential. The current American pharmaceutical industry needs substantial reform to deliver on that promise. In the
PBMs obscure pricing for purchasers. Most purchasers don’t know how to negotiate the costs of drugs even when given the opportunity. In addition, their consultants and advisors don’t either. Even more troubling is the fact that most providers do a poor job understanding the efficacy of the drugs that they prescribe. Our analysis of very large employer claims data proves this out where we were able to apportion NDC11 data to diagnosis. The opportunity to create optimized efficacy is here now. We know what the FDA endpoints (goals) are for specific drugs. So, while negotiating prices on drugs is a good first step; there are many other opportunities to make drug purchasing and drug prescribing.......better and more focused on optimized outcomes for patients.
Sep 26, 2022·edited Sep 27, 2022Liked by William H Bestermann Jr MD
Yes. Our the central element of this revolutionary change is to establish an independent, decentralized, individually owned and monetized, grassroots monitored, managed, and vetted data networks designed for the 21st Century to allow thorough reproducible verification and validation of ALL the devices, tests, procedures, and most importantly the pharmaceuticals to ensure that they indeed are safe and effective without the politics, the corruption, and the gaslighting of the masses. No more lies, deception, and plundering of public funding. We must deliver the best outcomes for the lowest cost and the safest, and most effective everything we prescribe to serve our patients with transparency, integrity, and honesty. This GRASS ROOT Uprising will save mankind from ruins of the “expert opinions” driven late stage sickness seeking profiteering 19th Century Legacy American Medical Industrial Complex Kabuki Dance Theatrics! ENOUGH!
Yup! Multifunction Cardiogram Technology Platform will lead the fundamental transformation of the industry’s digital information infrastructure designs to ensure that our development will succeed!
Absolutely. Thank you for illustrating key issues impacting the major players strategically being part of the solution rather than perpetuate the problems, making them worse.
PBMs obscure pricing for purchasers. Most purchasers don’t know how to negotiate the costs of drugs even when given the opportunity. In addition, their consultants and advisors don’t either. Even more troubling is the fact that most providers do a poor job understanding the efficacy of the drugs that they prescribe. Our analysis of very large employer claims data proves this out where we were able to apportion NDC11 data to diagnosis. The opportunity to create optimized efficacy is here now. We know what the FDA endpoints (goals) are for specific drugs. So, while negotiating prices on drugs is a good first step; there are many other opportunities to make drug purchasing and drug prescribing.......better and more focused on optimized outcomes for patients.
You do know how and your knowledge will be critical to progress. Let's work on all the opportunities.
Yes. Our the central element of this revolutionary change is to establish an independent, decentralized, individually owned and monetized, grassroots monitored, managed, and vetted data networks designed for the 21st Century to allow thorough reproducible verification and validation of ALL the devices, tests, procedures, and most importantly the pharmaceuticals to ensure that they indeed are safe and effective without the politics, the corruption, and the gaslighting of the masses. No more lies, deception, and plundering of public funding. We must deliver the best outcomes for the lowest cost and the safest, and most effective everything we prescribe to serve our patients with transparency, integrity, and honesty. This GRASS ROOT Uprising will save mankind from ruins of the “expert opinions” driven late stage sickness seeking profiteering 19th Century Legacy American Medical Industrial Complex Kabuki Dance Theatrics! ENOUGH!
I like this. Transparent data that serves the patients is the key. We keep talking about patient-centeredness. It is time to actually do it.
This must be done to keep everyone honest.
Yup! Multifunction Cardiogram Technology Platform will lead the fundamental transformation of the industry’s digital information infrastructure designs to ensure that our development will succeed!
Absolutely. Thank you for illustrating key issues impacting the major players strategically being part of the solution rather than perpetuate the problems, making them worse.
Thanks Jeff. Your efforts to bring stakeholders together are essential for success. Patients, employers, and providers have aligned interests here.